Bayer shares surge after U.S. Supreme Court rules in favour of company
Bayer shares surge after U.S. Supreme Court rules in favour of company LONDON, June 25 (Reuters) - Shares in Germany's Bayer BAYGn.DE surged by the most in 23 years on Thursday after the U.S. Supreme Court sided with the the company concerning lawsuits related its Roundup weedkiller.
The Supreme Court reined in thousands of lawsuits pursued in the state courts that had accused Bayer of failing to warn users that the active ingredient in Roundup causes cancer, handing a major legal victory to the company.
At 1419 GMT, shares were up 17.3%, heading for their biggest daily jump since 2003.
(Reporting by Samuel Indyk; Editing by Amanda Cooper)
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women